Polymorphic AAAG repeat length in estrogen-related receptor gamma (errγ) and risk of breast cancer in iranian women

Cancer Investigation

Volumn 31, Issue 9, 2013, Pages 600-603

  Karimi, Padideh ^a   Hematti, Simin ^b   Safari, Foruzan ^b   Tavassoli, Manoochehr ^a  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; ERR ; Microsatellite; Polymorphism

Indexed keywords

ESTROGEN RELATED RECEPTOR GAMMA; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INTRON; IRAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TETRATRICOPEPTIDE REPEAT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; IRAN; MICROSATELLITE REPEATS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RISK FACTORS;

EID: 84887255073     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357907.2013.845672     Document Type: Article

References (21)

1. Marsden CG, Wright MJ, Carrier L, Moroz K, Pochampally R, Rowan BG. A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies. Bio Med Central (BMC) Cancer 2012;12:1-16.
2. Saghir NSE, Adebamowo CA, Anderson BO, Carlson RW, Bird PA, CorbexM, BadweRA, BushnaqMA, EniuA, Gralow JR,Harness JK, Masetti R, Perry F, Samiei M, Thomas DB, Wiafe-Addai B, Cazap E. Breast cancer management in low resource countries LRCs. : consensus statement fromthe Breast Health Global Initiative. Breast 2011;20:S3-S11.
3. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence andmortality in Iran. AnnOncol 2009;20:556-563.
4. Riggins RB,Mazzotta MM,Maniya OZ, Clarke R. Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response. Endocr Relat Cancer 2010;17:R213-R231.
5. Zhang Z, Teng CT. Interplay between estrogen-related receptor alpha ERR?. and gamma ERR? on the regulation of ERR? gene expression. Mol Cell Endocrinol 2007;264:128-141.
6. Sun P, Wei L, Denkert C, Lichtenegger W, Sehouli J. The orphan nuclear receptors, estrogen receptor-related receptors: their role as new biomarkers in gynecological cancer. Anticancer Res 2006;26:1699-1706.
7. Giguere V. To ERR in the estrogen pathway. Trends Endocrinol Metab 2002;13:220-225.
8. Heard DJ, Norby PL, Holloway J, Vissing H. Human ERRgamma, a third member of the estrogen receptor-related receptor ERR. subfamily of orphan nuclear receptors: tissue specific isoforms are expressed during development and in the adult. Mol Endocrinol 2000;14:382-392.
9. Ariazi EA, Jordan VC. Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem 2006;6:203-215.
10. Riggins RB, Lan JP, Klimach U, Zwart A, Cavalli LR, Haddad BR, Chen L, Gong T, Xuan J, Ethier SP, Clarke R. ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res 2008;68:8908-8917.
11. Gebhardt F, Z̈anker KS, Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron. J Biol Chem 1990;274:13176-13180.
12. Bontekoe CJ, Bakker CE, Nieuwenhuizen IM, van der Linde H, Lans H, de Lange D, Hirst MC, Oostra BA. Instability of a (CGG)98 repeat in the Fmr1 promoter. Hum Mol Genet 2001;10:1693-1699.
13. Fondon JW, Garner HR. Molecular origins of rapid and continuous morphological evolution. Proc Natl Acad Sci 2004;101:18058-18063.
14. Galindo CL,McCormick JF, Bubb VJ, Abid Alkadem DH, Li LSH, McIver LJ, George AC, Boothman DA, Quinn JP, Skinner MA, Garner HR. A long AAAG repeat allele in the 5- UTR of the ERR-γ gene is correlated with breast cancer predisposition and drives promoter activity in MCF-7 breast cancer cells. Breast Cancer Res Treat 2010;130:41-48.
15. Ao A, Wang H, Kamarajugadda S, Lu J. Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci USA 2008;105:7821-7826.
16. Ariazi EA, Clark GM, Mertz JE. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res 2002;62:6510-6518.
17. Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Fujimura T, Tsuda H, Osaki A, Saeki T, Inoue S. Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer. J Steroid Biochem Mol Biol 2011;123:1-7.
18. Tiraby C, Hazen BC, Gantner ML, Kralli A. Estrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth. Cancer Res 2011;71:2518-2528.
19. Eichner LJ, Perry MC, Dufour CR, Bertos N, Park M, St-Pierre J, Giguere V. miR-378 mediates metabolic shift in breast cancer cells via the PGC-1?/ERR? transcriptional pathway. Cell Metab 2010;12:352-361.
20. Jami MS, Hemati S, Salehi Z, Tavassoli M. Association between the length of a CA dinucleotide repeat in the EGFR and risk of breast cancer. Cancer Invest 2008;26:434-437.
21. Javadi M, Hematti S, Tavassoli M. Polymorphic CA repeat length in insulin-like growth factor 1 and risk of breast cancer in Iranian women. Med Oncol 2012;29:516-520.